Form 4 Filing for Camp4 Therapeutics Corp

This filing details a Form 4 submission for Camp4 Therapeutics Corp, reporting ownership changes by Gold Kelly, the Chief Financial Officer. On April 1, 2026, Mr. Kelly was granted 215,000 stock options to purchase the company's common stock at an exercise price of $4.46 per share. These options vest over four years, with monthly installments. The options have an expiration date of March 31, 2036. The filing indicates that Mr. Kelly holds these options directly. This transaction is considered a stock option grant, which is a common form of equity compensation for executives. The reporting owner, Gold Kelly, has a direct ownership nature in this transaction.